The Newfoundland and Labrador health authority said that it has identified 38 patients from Eastern Health's region who meet the criteria for re-testing, 24 out of these are no longer alive.
The release said: "In an effort to ensure that we identify as many potentially affected individuals as possible, and given previously recognized challenges with internal information systems, in November, Eastern Health engaged the services of the NL Centre for Health Information. During the past week, NLCHI has provided a number of patient charts for clarification."
Tests on kids suffering from cerebral palsy or mental disabilities in Punjab have disclosed high levels of uranium.
A charity based in the Punjab’s Faridkot city said chemical analyses of hair samples collected from 149 children in its care showed "unpredicted quantities" of toxicants.
The kids who took part in the study were below the age of 13 years, it said.
The outcome has puzzled the functionaries as there are no known sources of uranium in Punjab.
A decade-long research conducted by the Tata Memorial Hospital, and backed by the Bill & Melinda Gates Foundation, has reached a noteworthy conclusion with regard to detection of cervical cancer.
According to the study, genetic testing for human papilloma virus or HPV - by collecting DNA cells from the cervix - was a better method for detecting cervical cancer in comparison to the widely popular method called 'pap smear,' in which cells are collected from the surface of the cervix.
Recent study revealed an association in germs in mouths and increased risk of heart disease. This study gave the clear indication that oral hygiene has effect on cardio-vascular health.
Researchers at the University at Buffalo analyzed data collected from 386 men and women (35 to 69 years of age) who had suffered a heart attack and
Elan Corp., Plc. and Wyeth decided to stop the ongoing clinical trails testing effect of 2.0 mg/kg dose of experimental Alzheimer's drug bapineuzumab.
Officials from both companies declared the discontinuation of the highest of the three dosing regimens, 2.0 mg/kg, in the two ongoing Phase 3 studies of bapineuzumab in patients with mild-to-moderate Alzheimer's disease, or AD, who do not carry the Apolipoprotein E4, or ApoE4, allele. However testing of the 0.5 mg/kg and 1.0 mg/kg doses in two Phase III trials will continue as planned.
The Newfoundland and Labrador health authority said that it has identified 38 patients from Eastern Health's region who meet the criteria for re-testing, 24 out of these are no longer alive. 
Tests on kids suffering from cerebral palsy or mental disabilities in Punjab have disclosed high levels of uranium.
A decade-long research conducted by the Tata Memorial Hospital, and backed by the Bill & Melinda Gates Foundation, has reached a noteworthy conclusion with regard to detection of cervical cancer.
Recent study revealed an association in germs in mouths and increased risk of heart disease. This study gave the clear indication that oral hygiene has effect on cardio-vascular health. 
Elan Corp., Plc. and Wyeth decided to stop the ongoing clinical trails testing effect of 2.0 mg/kg dose of experimental Alzheimer's drug bapineuzumab. 
